Physician profile
Nitisha Mutgi
NPI 1750640165
$1,335.43
in general payments reported to CMS, 2019-2025
21 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2021: $180 · 2022: $78.70 · 2023: $367 · 2024: $377 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.11 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $176.87 | 2023-2025 | Veozah |
| Abbvie INC. | $165.74 | 2019-2023 | |
| Sage Therapeutics, LLC | $146.60 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $114.78 | 2021-2025 | Acessa Provu System, Fluent Fluid Management System, Novasure |
| Lupin INC. | $103.03 | 2019 | |
| Organon LLC | $94.60 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $89.51 | 2021-2024 | Slynd |
| Baxter Healthcare | $71.44 | 2024 | Perclot |
| Aspira Women'S Health INC | $71.32 | 2023 | Ova1 |
| Sumitomo Pharma America, INC. | $53.50 | 2023-2024 | Myfembree |
| Mayne Pharma Commercial LLC | $45.01 | 2021-2024 | |
| Therapeuticsmd, INC. | $43.44 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $31.31 | 2019 | |
| Exact Sciences Corporation | $18.59 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $18.25 | 2025 | Gardasil 9 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $18.05 | 2025 | Qelbree |
| Daiichi Sankyo INC. | $16.74 | 2021 | |
| Agile Therapeutics, INC. | $15.94 | 2021 | |
| Minerva Surgical, INC | $15.17 | 2023 | |
| Pfizer INC. | $14.54 | 2023 | |
| Alexion Pharmaceuticals, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitisha Mutgi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.